In addition, DC prepared from CRC patients were 87%-80% positive for DR/CD11C and 84%-71% positive for CD83 (Fig. 3A, B), and CIK cells from CRC patients were 75%-48% positive for CD3/CD8 and 41%-11% positive for CD3/CD56 respectively (Fig. 3C, D). This evidence concerns the gene ITGAX and colorectal carcinoma.